Insider Transactions for Crinetics Pharmaceuticals, Inc. (CRNX)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
CRNXCrinetics Pharmaceuticals, Inc.Knight Jeff E.Chief Operating OfficerMar 22, 2024Sale$34.5362,3592,153,07584,939Mar 26, 2024, 04:30 PM
CRNXCrinetics Pharmaceuticals, Inc.Pizzuti DanaChief Med and Dev OfficerMar 20, 2024Sale$30.8029,464907,55738,500Mar 22, 2024, 04:52 PM
CRNXCrinetics Pharmaceuticals, Inc.Fust Matthew KDirectorMar 20, 2024Sale$32.53120,0003,903,12536,036Mar 22, 2024, 04:31 PM
CRNXCrinetics Pharmaceuticals, Inc.Pizzuti DanaChief Med and Dev OfficerMar 18, 2024Option Exercise$38.1441115,67628,500Mar 20, 2024, 06:36 PM
CRNXCrinetics Pharmaceuticals, Inc.Knight Jeff E.Chief Operating OfficerMar 18, 2024Option Exercise$38.144,283163,35454,939Mar 20, 2024, 06:35 PM
CRNXCrinetics Pharmaceuticals, Inc.Hassard JamesChief Commercial OfficerMar 18, 2024Option Exercise$38.141,74166,40229,259Mar 20, 2024, 06:34 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerMar 18, 2024Option Exercise$38.143,655139,40292,643Mar 20, 2024, 06:33 PM
CRNXCrinetics Pharmaceuticals, Inc.Wilson MarcCFOMar 18, 2024Option Exercise$38.143,983151,912117,572Mar 20, 2024, 06:32 PM
CRNXCrinetics Pharmaceuticals, Inc.Wilson MarcCFOMar 19, 2024Sale$42.916,942297,881110,630Mar 20, 2024, 06:32 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOMar 18, 2024Option Exercise$38.1412,687483,882237,835Mar 20, 2024, 06:31 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerJan 25, 2024Sale$37.263,000111,78073,298Jan 26, 2024, 05:50 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerJan 10, 2024Sale$37.653,000112,95076,298Jan 12, 2024, 04:12 PM
CRNXCrinetics Pharmaceuticals, Inc.Pizzuti DanaChief Med and Dev OfficerJan 03, 2024Option Exercise$25.9428,750745,91920,286Jan 04, 2024, 04:45 PM
CRNXCrinetics Pharmaceuticals, Inc.Wilson MarcCFOJan 02, 2024Option Exercise$22.3820,000447,500106,055Jan 04, 2024, 04:43 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerDec 26, 2023Sale$35.893,000107,67079,298Dec 27, 2023, 05:20 PM
CRNXCrinetics Pharmaceuticals, Inc.Pizzuti DanaChief Med and Dev OfficerDec 21, 2023Option Exercise$25.7319,166493,14115,494Dec 22, 2023, 06:45 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerDec 11, 2023Sale$32.873,00098,61082,298Dec 13, 2023, 04:44 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerNov 27, 2023Sale$31.843,00095,52085,298Nov 29, 2023, 04:31 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEONov 09, 2023Option Exercise$1.9150,00095,500185,522Nov 13, 2023, 04:33 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEONov 02, 2023Option Exercise$19.621,83636,013136,440Nov 06, 2023, 06:02 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEONov 03, 2023Sale$19.92398,1647,931,427334,604Nov 06, 2023, 06:02 PM
CRNXCrinetics Pharmaceuticals, Inc.Wilson MarcCFONov 01, 2023Option Exercise$19.0120,000380,300105,601Nov 03, 2023, 07:38 PM
CRNXCrinetics Pharmaceuticals, Inc.Krasner Alan SethChief Medical OfficerOct 17, 2023Sale$21.0114,000294,07050,210Oct 19, 2023, 05:01 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOAug 14, 2023Option Exercise$1.9110,00019,100135,522Aug 16, 2023, 04:30 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOJul 12, 2023Sale$20.1711,459231,128644,962Jul 13, 2023, 04:56 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOJul 13, 2023Sale$20.3514,157288,095630,805Jul 13, 2023, 04:56 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOJul 11, 2023Sale$20.1424,384491,094656,421Jul 13, 2023, 04:56 PM
CRNXCrinetics Pharmaceuticals, Inc.Wilson MarcCFOJun 20, 2023Sale$15.7750,922803,003115,158Jun 21, 2023, 05:32 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOJun 16, 2023Sale$20.8150,0001,040,500680,805Jun 21, 2023, 05:27 PM
CRNXCrinetics Pharmaceuticals, Inc.Vivaldi Coelho RogerioDirectorJun 08, 2023Buy$22.065,000110,3005,000Jun 09, 2023, 08:00 AM
CRNXCrinetics Pharmaceuticals, Inc.Pizzuti DanaChief Development OfficerApr 05, 2023Sale$16.158,212132,6244,500Apr 05, 2023, 07:12 PM
CRNXCrinetics Pharmaceuticals, Inc.Pizzuti DanaChief Development OfficerApr 03, 2023Option Exercise$15.984,28868,52212,712Apr 05, 2023, 07:12 PM
CRNXCrinetics Pharmaceuticals, Inc.Wilson MarcCFOMar 16, 2023Option Exercise$17.121,66628,522106,080Mar 17, 2023, 05:11 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOMar 16, 2023Option Exercise$17.124,62879,231125,522Mar 17, 2023, 05:10 PM
CRNXCrinetics Pharmaceuticals, Inc.Krasner Alan SethChief Medical OfficerMar 16, 2023Option Exercise$17.121,68728,88142,301Mar 17, 2023, 05:09 PM
CRNXCrinetics Pharmaceuticals, Inc.Knight Jeff E.Chief Operating OfficerMar 16, 2023Option Exercise$17.1258710,04934,400Mar 17, 2023, 05:08 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerMar 16, 2023Option Exercise$17.121,41024,13986,879Mar 17, 2023, 05:07 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerFeb 01, 2023Sale$19.593,12661,23864,689Feb 03, 2023, 04:30 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerJan 25, 2023Sale$21.078,336175,64067,815Jan 27, 2023, 04:26 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerJan 17, 2023Sale$18.003,12656,26876,151Jan 19, 2023, 04:28 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerJan 03, 2023Sale$18.353,12657,36279,277Jan 05, 2023, 04:23 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerDec 15, 2022Sale$16.003,12650,01682,403Dec 19, 2022, 05:11 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerDec 01, 2022Sale$17.843,12655,76884,968Dec 05, 2022, 05:28 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerNov 15, 2022Sale$18.723,12658,51988,094Nov 17, 2022, 04:46 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerNov 01, 2022Sale$18.523,12657,89491,220Nov 03, 2022, 04:35 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerOct 17, 2022Sale$17.733,12655,42494,346Oct 19, 2022, 05:34 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOOct 12, 2022Option Exercise$1.9111,10021,20168,500Oct 14, 2022, 04:55 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerOct 03, 2022Sale$19.643,12661,39597,472Oct 05, 2022, 04:40 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerSep 15, 2022Sale$21.014,16887,570100,598Sep 19, 2022, 04:40 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerSep 07, 2022Sale$21.001,04221,884104,766Sep 09, 2022, 04:20 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerMay 20, 2022Option Exercise$11.021,33614,723108,934Sep 06, 2022, 04:20 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerSep 01, 2022Sale$18.593,12658,112105,808Sep 06, 2022, 04:20 PM
CRNXCrinetics Pharmaceuticals, Inc.Knight Jeff E.Chief Operating OfficerMay 20, 2022Option Exercise$17.441,15220,0916,102Jul 29, 2022, 04:26 PM
CRNXCrinetics Pharmaceuticals, Inc.Knight Jeff E.Chief Operating OfficerJul 26, 2022Sale$20.701,15223,8474,950Jul 29, 2022, 04:26 PM
CRNXCrinetics Pharmaceuticals, Inc.Fust Matthew KDirectorJul 13, 2022Option Exercise$11.2011,400127,72018,236Jul 15, 2022, 04:30 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerMay 02, 2022Sale$20.103,24765,252107,598May 04, 2022, 05:01 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerApr 18, 2022Sale$25.815,664146,188110,845Apr 21, 2022, 05:00 PM
CRNXCrinetics Pharmaceuticals, Inc.PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10% OwnerApr 18, 2022Buy$22.22157,5153,499,9835,321,032Apr 18, 2022, 05:39 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOApr 13, 2022Sale$26.83138,6433,719,625844,774Apr 15, 2022, 06:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOApr 05, 2022Sale$25.3421,357541,225869,448Apr 07, 2022, 05:58 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerApr 04, 2022Sale$23.979,000215,761116,509Apr 06, 2022, 07:08 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerMar 31, 2022Sale$21.064,16487,700129,673Apr 01, 2022, 05:39 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerApr 01, 2022Sale$21.804,16490,775125,509Apr 01, 2022, 05:39 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerMar 15, 2022Sale$18.943,12359,150133,837Mar 17, 2022, 04:33 PM
CRNXCrinetics Pharmaceuticals, Inc.Madan AjayChief Development OfficerMar 01, 2022Sale$19.889,000178,920176,995Mar 02, 2022, 09:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerMar 01, 2022Sale$19.733,12361,617136,960Mar 02, 2022, 09:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerFeb 15, 2022Sale$18.643,12358,213123,583Feb 17, 2022, 04:34 PM
CRNXCrinetics Pharmaceuticals, Inc.Madan AjayChief Development OfficerFeb 07, 2022Sale$17.8313,411239,085172,045Feb 09, 2022, 05:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerFeb 01, 2022Sale$18.793,12358,681126,706Feb 03, 2022, 04:30 PM
CRNXCrinetics Pharmaceuticals, Inc.Krasner Alan SethChief Medical OfficerJan 19, 2022Option Exercise$16.6113,400222,54715,011Jan 21, 2022, 04:54 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerJan 18, 2022Sale$23.294,16897,073128,875Jan 20, 2022, 04:47 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerJan 03, 2022Sale$28.027,168200,847133,043Jan 06, 2022, 04:37 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerDec 28, 2021Sale$27.953,00083,852140,211Dec 30, 2021, 07:19 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerDec 15, 2021Sale$24.145,668136,826143,211Dec 17, 2021, 04:28 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerDec 01, 2021Sale$27.385,668155,190148,879Dec 03, 2021, 04:36 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerNov 16, 2021Sale$27.971,50041,955154,547Nov 17, 2021, 05:01 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerNov 15, 2021Sale$26.755,668151,619156,047Nov 17, 2021, 05:01 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerNov 05, 2021Sale$27.9512,600352,195165,615Nov 09, 2021, 05:44 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerNov 08, 2021Sale$28.423,900110,846161,715Nov 09, 2021, 05:44 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerNov 01, 2021Sale$24.795,668140,510178,215Nov 03, 2021, 04:57 PM
CRNXCrinetics Pharmaceuticals, Inc.Fust Matthew KDirectorNov 01, 2021Option Exercise$13.7017,908245,42921,490Nov 03, 2021, 04:55 PM
CRNXCrinetics Pharmaceuticals, Inc.Madan AjayChief Development OfficerOct 28, 2021Option Exercise$0.73106,38377,660184,671Nov 01, 2021, 07:11 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerOct 27, 2021Sale$24.003,00071,991183,883Oct 28, 2021, 05:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Betz Stephen F.Chief Scientific OfficerOct 21, 2021Sale$21.101,04221,984186,883Oct 25, 2021, 04:28 PM
CRNXCrinetics Pharmaceuticals, Inc.PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10% OwnerOct 25, 2021Buy$19.801,200,00023,759,9995,163,517Oct 25, 2021, 02:47 PM
CRNXCrinetics Pharmaceuticals, Inc.Fust Matthew KDirectorSep 08, 2021Option Exercise$13.7012,092165,72118,582Sep 09, 2021, 05:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOSep 07, 2021Sale$25.0010,000250,00090,000Sep 09, 2021, 05:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOSep 07, 2021Sale$25.0010,000250,00090,000Sep 09, 2021, 05:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOSep 07, 2021Sale$25.0010,000250,00090,000Sep 09, 2021, 05:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Fust Matthew KDirectorJul 26, 2021Option Exercise$10.7510,000107,50017,536Jul 27, 2021, 08:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Fust Matthew KDirectorJul 19, 2021Option Exercise$10.7010,000107,05017,536Jul 20, 2021, 05:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Fust Matthew KDirectorJul 12, 2021Option Exercise$11.3110,000113,10017,536Jul 13, 2021, 05:00 PM
CRNXCrinetics Pharmaceuticals, Inc.PERCEPTIVE ADVISORS LLC10% OwnerApr 08, 2021Buy$16.44304,1364,999,9963,963,517Apr 09, 2021, 09:00 AM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEODec 02, 2020Buy$12.601,00012,6001,000Dec 04, 2020, 04:59 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEODec 03, 2020Buy$13.104,00052,4004,000Dec 04, 2020, 04:59 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOJul 15, 2020Sale$15.3017,500267,722908,305Jul 17, 2020, 05:05 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOJul 16, 2020Sale$14.4617,500253,108890,805Jul 17, 2020, 05:05 PM
CRNXCrinetics Pharmaceuticals, Inc.WIERENGA WENDALLDirectorApr 28, 2020Option Exercise$0.7325,32918,49099,846Apr 29, 2020, 05:01 PM
CRNXCrinetics Pharmaceuticals, Inc.EDELMAN JOSEPH10% OwnerApr 17, 2020Buy$14.001,071,42814,999,9923,659,381Apr 20, 2020, 08:30 AM
CRNXCrinetics Pharmaceuticals, Inc.Vivo Capital Surplus Fund VIII, L.P.10% OwnerApr 15, 2020Sale$15.50215,8103,345,0552,263,447Apr 17, 2020, 06:38 PM